Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.85721267 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.44073173 |
3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.21422243 |
4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.02220145 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.93470525 |
6 | negative regulation of cell killing (GO:0031342) | 4.93470525 |
7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.47592300 |
8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.46263899 |
9 | immunoglobulin mediated immune response (GO:0016064) | 4.31492444 |
10 | positive thymic T cell selection (GO:0045059) | 4.19472724 |
11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.09936428 |
12 | neutrophil activation involved in immune response (GO:0002283) | 4.09026544 |
13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06109257 |
14 | negative T cell selection (GO:0043383) | 4.03381734 |
15 | positive T cell selection (GO:0043368) | 3.93246818 |
16 | positive regulation of B cell differentiation (GO:0045579) | 3.89042144 |
17 | negative thymic T cell selection (GO:0045060) | 3.86966432 |
18 | negative regulation of interleukin-12 production (GO:0032695) | 3.85446473 |
19 | T cell migration (GO:0072678) | 3.75074823 |
20 | leukocyte aggregation (GO:0070486) | 3.69972482 |
21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.69922406 |
22 | cellular response to interleukin-15 (GO:0071350) | 3.69001166 |
23 | response to interleukin-15 (GO:0070672) | 3.65418760 |
24 | neutrophil activation (GO:0042119) | 3.61146819 |
25 | regulation of regulatory T cell differentiation (GO:0045589) | 3.59568461 |
26 | cellular extravasation (GO:0045123) | 3.55512846 |
27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.54176324 |
28 | response to peptidoglycan (GO:0032494) | 3.53210329 |
29 | regulation of T cell tolerance induction (GO:0002664) | 3.51413377 |
30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.50034758 |
31 | B cell mediated immunity (GO:0019724) | 3.49996166 |
32 | regulation of tolerance induction (GO:0002643) | 3.48240440 |
33 | modulation by symbiont of host defense response (GO:0052031) | 3.47990663 |
34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47990663 |
35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47990663 |
36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47990663 |
37 | modulation by symbiont of host immune response (GO:0052553) | 3.47990663 |
38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47990663 |
39 | regulation of B cell differentiation (GO:0045577) | 3.47019539 |
40 | mast cell activation (GO:0045576) | 3.45612577 |
41 | detection of molecule of bacterial origin (GO:0032490) | 3.44014115 |
42 | granulocyte activation (GO:0036230) | 3.42500938 |
43 | detection of other organism (GO:0098543) | 3.40702634 |
44 | B cell receptor signaling pathway (GO:0050853) | 3.35527490 |
45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35250129 |
46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34950935 |
47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34580599 |
48 | cytidine metabolic process (GO:0046087) | 3.31554471 |
49 | cytidine catabolic process (GO:0006216) | 3.31554471 |
50 | cytidine deamination (GO:0009972) | 3.31554471 |
51 | cellular response to type I interferon (GO:0071357) | 3.31274261 |
52 | type I interferon signaling pathway (GO:0060337) | 3.31274261 |
53 | T cell selection (GO:0045058) | 3.29518857 |
54 | response to type I interferon (GO:0034340) | 3.29393777 |
55 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.26098683 |
56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.24555303 |
57 | detection of external biotic stimulus (GO:0098581) | 3.24286127 |
58 | positive regulation of tolerance induction (GO:0002645) | 3.24054476 |
59 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.22732122 |
60 | macrophage activation involved in immune response (GO:0002281) | 3.21788777 |
61 | detection of bacterium (GO:0016045) | 3.21427153 |
62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19694401 |
63 | myeloid cell activation involved in immune response (GO:0002275) | 3.19327600 |
64 | microglial cell activation (GO:0001774) | 3.19057696 |
65 | interferon-gamma production (GO:0032609) | 3.18575122 |
66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16314812 |
67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15786036 |
68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13392680 |
69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09048949 |
70 | thymic T cell selection (GO:0045061) | 3.08981206 |
71 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.06380113 |
72 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.05995227 |
73 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.05995227 |
74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00523194 |
75 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.99230882 |
76 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98064624 |
77 | T cell receptor signaling pathway (GO:0050852) | 2.97617497 |
78 | regulation of antigen processing and presentation (GO:0002577) | 2.97470895 |
79 | leukocyte degranulation (GO:0043299) | 2.97209672 |
80 | activated T cell proliferation (GO:0050798) | 2.96747751 |
81 | response to interferon-beta (GO:0035456) | 2.96130171 |
82 | detection of biotic stimulus (GO:0009595) | 2.95407477 |
83 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94320801 |
84 | lymphocyte chemotaxis (GO:0048247) | 2.93621522 |
85 | defense response to protozoan (GO:0042832) | 2.93402551 |
86 | DNA deamination (GO:0045006) | 2.90467866 |
87 | tolerance induction (GO:0002507) | 2.90004782 |
88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89935630 |
89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89272726 |
90 | mature B cell differentiation involved in immune response (GO:0002313) | 2.88348325 |
91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87539774 |
92 | respiratory burst (GO:0045730) | 2.86766950 |
93 | positive regulation of mast cell activation (GO:0033005) | 2.86682642 |
94 | regulation of mast cell activation (GO:0033003) | 2.85939785 |
95 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.85634630 |
96 | T cell costimulation (GO:0031295) | 2.85448538 |
97 | positive regulation of defense response to virus by host (GO:0002230) | 2.84453143 |
98 | negative regulation of viral genome replication (GO:0045071) | 2.84351047 |
99 | negative regulation of innate immune response (GO:0045824) | 2.83777383 |
100 | regulation of mast cell degranulation (GO:0043304) | 2.82256271 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.67575031 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.55659099 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.90686572 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.86162335 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.32600439 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.24469540 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.48063476 |
8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.39655513 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19644563 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.09967374 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98283468 |
12 | MYB_26560356_Chip-Seq_TH2_Human | 2.91721927 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80014350 |
14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52570047 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.51980270 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42691481 |
17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31800141 |
18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.29769641 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29555299 |
20 | MYB_26560356_Chip-Seq_TH1_Human | 2.28221416 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27933975 |
22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26283813 |
23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.08882620 |
24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00357208 |
25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.97574368 |
26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95834901 |
27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95484802 |
28 | MAF_26560356_Chip-Seq_TH1_Human | 1.94874968 |
29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94646194 |
30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.93134839 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92587289 |
32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87195535 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81665868 |
34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78475294 |
35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77423756 |
36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76858291 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69631073 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62669796 |
39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59046441 |
40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56349444 |
41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49443469 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48877964 |
43 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35137454 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34937181 |
45 | MAF_26560356_Chip-Seq_TH2_Human | 1.34128509 |
46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32503173 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31037050 |
48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27864123 |
49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21954444 |
50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19692379 |
51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19298405 |
52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17923944 |
53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17432258 |
54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14746099 |
55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14473208 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11614131 |
57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10833756 |
58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08245744 |
59 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06134904 |
60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05789920 |
61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04930287 |
62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03906474 |
63 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00622763 |
64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98953980 |
65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96029358 |
66 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92989595 |
67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91709560 |
68 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91567938 |
69 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89067194 |
70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88870344 |
71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84936529 |
72 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84110001 |
73 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83629900 |
74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83270219 |
75 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.82947489 |
76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82780053 |
77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.81651145 |
78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81270942 |
79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78208278 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77597277 |
81 | MYC_22102868_ChIP-Seq_BL_Human | 0.77441165 |
82 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76470724 |
83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75755133 |
84 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75163697 |
85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74886724 |
86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.74866377 |
87 | P300_27268052_Chip-Seq_Bcells_Human | 0.73530207 |
88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.72927527 |
89 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70702084 |
90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70659733 |
91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69189600 |
92 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68821632 |
93 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68216204 |
94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.68197940 |
95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.68002664 |
96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.67486645 |
97 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67056934 |
98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66496255 |
99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.65962953 |
100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65602808 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 4.30625132 |
2 | MP0001835_abnormal_antigen_presentation | 4.23121703 |
3 | MP0003724_increased_susceptibility_to | 4.16790081 |
4 | MP0003436_decreased_susceptibility_to | 3.52778968 |
5 | MP0009785_altered_susceptibility_to | 3.40200394 |
6 | MP0001800_abnormal_humoral_immune | 3.13838848 |
7 | MP0005000_abnormal_immune_tolerance | 3.10612217 |
8 | MP0002148_abnormal_hypersensitivity_rea | 2.96506680 |
9 | MP0005025_abnormal_response_to | 2.84824730 |
10 | MP0000685_abnormal_immune_system | 2.82481208 |
11 | MP0002723_abnormal_immune_serum | 2.78148067 |
12 | MP0001790_abnormal_immune_system | 2.77493781 |
13 | MP0005387_immune_system_phenotype | 2.77493781 |
14 | MP0002419_abnormal_innate_immunity | 2.76464591 |
15 | MP0006082_CNS_inflammation | 2.73729997 |
16 | MP0003763_abnormal_thymus_physiology | 2.68545670 |
17 | MP0002452_abnormal_antigen_presenting | 2.67138773 |
18 | MP0002420_abnormal_adaptive_immunity | 2.59544772 |
19 | MP0001819_abnormal_immune_cell | 2.56765985 |
20 | MP0003303_peritoneal_inflammation | 2.44808579 |
21 | MP0002405_respiratory_system_inflammati | 2.08910535 |
22 | MP0005464_abnormal_platelet_physiology | 2.01219027 |
23 | MP0002398_abnormal_bone_marrow | 1.99301394 |
24 | MP0000716_abnormal_immune_system | 1.98278956 |
25 | MP0009764_decreased_sensitivity_to | 1.97344113 |
26 | MP0002166_altered_tumor_susceptibility | 1.94797371 |
27 | MP0010155_abnormal_intestine_physiology | 1.93759612 |
28 | MP0001533_abnormal_skeleton_physiology | 1.91482902 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.86650069 |
30 | MP0001845_abnormal_inflammatory_respons | 1.82823590 |
31 | MP0004947_skin_inflammation | 1.74785579 |
32 | MP0000689_abnormal_spleen_morphology | 1.70475744 |
33 | MP0003866_abnormal_defecation | 1.69301431 |
34 | MP0000465_gastrointestinal_hemorrhage | 1.66835451 |
35 | MP0002722_abnormal_immune_system | 1.63799299 |
36 | MP0002429_abnormal_blood_cell | 1.53497139 |
37 | MP0001853_heart_inflammation | 1.51366392 |
38 | MP0008469_abnormal_protein_level | 1.49556876 |
39 | MP0000703_abnormal_thymus_morphology | 1.46195114 |
40 | MP0003300_gastrointestinal_ulcer | 1.44872636 |
41 | MP0001873_stomach_inflammation | 1.39327996 |
42 | MP0003191_abnormal_cellular_cholesterol | 1.39327008 |
43 | MP0002006_tumorigenesis | 1.38546633 |
44 | MP0009278_abnormal_bone_marrow | 1.38135935 |
45 | MP0000569_abnormal_digit_pigmentation | 1.36633618 |
46 | MP0003828_pulmonary_edema | 1.29957837 |
47 | MP0003172_abnormal_lysosome_physiology | 1.28367297 |
48 | MP0002933_joint_inflammation | 1.27925195 |
49 | MP0005310_abnormal_salivary_gland | 1.27452771 |
50 | MP0003448_altered_tumor_morphology | 1.23834702 |
51 | MP0002998_abnormal_bone_remodeling | 1.22572779 |
52 | MP0001545_abnormal_hematopoietic_system | 1.22406048 |
53 | MP0005397_hematopoietic_system_phenotyp | 1.22406048 |
54 | MP0002138_abnormal_hepatobiliary_system | 1.19920005 |
55 | MP0003806_abnormal_nucleotide_metabolis | 1.16520728 |
56 | MP0003075_altered_response_to | 1.12339407 |
57 | MP0004883_abnormal_blood_vessel | 1.06280754 |
58 | MP0002277_abnormal_respiratory_mucosa | 1.05420365 |
59 | MP0005166_decreased_susceptibility_to | 1.04295557 |
60 | MP0000858_altered_metastatic_potential | 1.03444409 |
61 | MP0003183_abnormal_peptide_metabolism | 1.01270281 |
62 | MP0001851_eye_inflammation | 1.01013064 |
63 | MP0008260_abnormal_autophagy | 0.99656108 |
64 | MP0005451_abnormal_body_composition | 0.99323667 |
65 | MP0003045_fibrosis | 0.99214830 |
66 | MP0005058_abnormal_lysosome_morphology | 0.98406082 |
67 | MP0005075_abnormal_melanosome_morpholog | 0.96908613 |
68 | MP0009763_increased_sensitivity_to | 0.94917650 |
69 | MP0000343_altered_response_to | 0.94218021 |
70 | MP0004381_abnormal_hair_follicle | 0.94179530 |
71 | MP0000604_amyloidosis | 0.92783633 |
72 | MP0002132_abnormal_respiratory_system | 0.91482759 |
73 | MP0005164_abnormal_response_to | 0.90542982 |
74 | MP0002396_abnormal_hematopoietic_system | 0.89341383 |
75 | MP0002009_preneoplasia | 0.86846173 |
76 | MP0004510_myositis | 0.86117291 |
77 | MP0004808_abnormal_hematopoietic_stem | 0.83987321 |
78 | MP0005390_skeleton_phenotype | 0.82113812 |
79 | MP0000249_abnormal_blood_vessel | 0.81119519 |
80 | MP0009765_abnormal_xenobiotic_induced | 0.77536006 |
81 | MP0003656_abnormal_erythrocyte_physiolo | 0.75428967 |
82 | MP0008004_abnormal_stomach_pH | 0.74794311 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.73508997 |
84 | MP0001663_abnormal_digestive_system | 0.72711351 |
85 | MP0005410_abnormal_fertilization | 0.67917344 |
86 | MP0003690_abnormal_glial_cell | 0.67556614 |
87 | MP0001501_abnormal_sleep_pattern | 0.67271485 |
88 | MP0002019_abnormal_tumor_incidence | 0.61561728 |
89 | MP0000015_abnormal_ear_pigmentation | 0.60715282 |
90 | MP0005174_abnormal_tail_pigmentation | 0.59029774 |
91 | MP0003795_abnormal_bone_structure | 0.58757834 |
92 | MP0002332_abnormal_exercise_endurance | 0.56628322 |
93 | MP0006054_spinal_hemorrhage | 0.54317276 |
94 | MP0009840_abnormal_foam_cell | 0.53738116 |
95 | MP0002136_abnormal_kidney_physiology | 0.53396819 |
96 | MP0002693_abnormal_pancreas_physiology | 0.52580047 |
97 | MP0004484_altered_response_of | 0.51130515 |
98 | MP0001986_abnormal_taste_sensitivity | 0.50953667 |
99 | MP0008873_increased_physiological_sensi | 0.48901164 |
100 | MP0005319_abnormal_enzyme/_coenzyme | 0.47837018 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.52136672 |
2 | Stomatitis (HP:0010280) | 5.27868194 |
3 | T lymphocytopenia (HP:0005403) | 5.06108724 |
4 | Abnormality of T cell number (HP:0011839) | 4.93358594 |
5 | Myositis (HP:0100614) | 4.76632164 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.64511512 |
7 | Recurrent abscess formation (HP:0002722) | 4.53686053 |
8 | Eczematoid dermatitis (HP:0000976) | 4.40215400 |
9 | Optic neuritis (HP:0100653) | 4.36575345 |
10 | Retrobulbar optic neuritis (HP:0100654) | 4.36575345 |
11 | Orchitis (HP:0100796) | 4.25642479 |
12 | Recurrent fungal infections (HP:0002841) | 4.12403996 |
13 | Abnormality of macrophages (HP:0004311) | 4.05373406 |
14 | Abnormality of T cells (HP:0002843) | 3.96146741 |
15 | Autoimmune hemolytic anemia (HP:0001890) | 3.95907723 |
16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82207523 |
17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82191166 |
18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82191166 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.73113257 |
20 | Meningitis (HP:0001287) | 3.70052268 |
21 | Gastrointestinal infarctions (HP:0005244) | 3.58291645 |
22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.57991147 |
23 | Obstructive lung disease (HP:0006536) | 3.57991147 |
24 | Recurrent skin infections (HP:0001581) | 3.55460854 |
25 | Encephalitis (HP:0002383) | 3.51400638 |
26 | IgG deficiency (HP:0004315) | 3.50159645 |
27 | Mediastinal lymphadenopathy (HP:0100721) | 3.43911869 |
28 | Increased IgM level (HP:0003496) | 3.42563438 |
29 | Vasculitis (HP:0002633) | 3.40900371 |
30 | Pulmonary infiltrates (HP:0002113) | 3.33658931 |
31 | Hemoptysis (HP:0002105) | 3.29061136 |
32 | Leukocytosis (HP:0001974) | 3.28225326 |
33 | Keratoconjunctivitis sicca (HP:0001097) | 3.26715610 |
34 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.21019847 |
35 | Recurrent viral infections (HP:0004429) | 3.19046131 |
36 | Keratoconjunctivitis (HP:0001096) | 3.11809463 |
37 | Severe combined immunodeficiency (HP:0004430) | 3.07473514 |
38 | Abnormality of T cell physiology (HP:0011840) | 3.06161820 |
39 | Pustule (HP:0200039) | 2.95861761 |
40 | Abnormality of the prostate (HP:0008775) | 2.94594255 |
41 | Chest pain (HP:0100749) | 2.92051511 |
42 | Recurrent bronchitis (HP:0002837) | 2.91861743 |
43 | Panhypogammaglobulinemia (HP:0003139) | 2.89894199 |
44 | Eosinophilia (HP:0001880) | 2.88816889 |
45 | Abnormality of B cell number (HP:0010975) | 2.86028708 |
46 | Spontaneous hematomas (HP:0007420) | 2.86010939 |
47 | Abnormality of eosinophils (HP:0001879) | 2.84754641 |
48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81146946 |
49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81146946 |
50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81146946 |
51 | Granulocytopenia (HP:0001913) | 2.80821637 |
52 | Chronic diarrhea (HP:0002028) | 2.80216489 |
53 | Increased IgE level (HP:0003212) | 2.79275498 |
54 | Agammaglobulinemia (HP:0004432) | 2.69142193 |
55 | Arterial thrombosis (HP:0004420) | 2.67416179 |
56 | Urticaria (HP:0001025) | 2.66038623 |
57 | Gangrene (HP:0100758) | 2.63258154 |
58 | Epistaxis (HP:0000421) | 2.62034863 |
59 | Thyroiditis (HP:0100646) | 2.61727211 |
60 | Prolonged bleeding time (HP:0003010) | 2.59050599 |
61 | Pulmonary embolism (HP:0002204) | 2.57176476 |
62 | Gingivitis (HP:0000230) | 2.57039630 |
63 | Gingival bleeding (HP:0000225) | 2.55303313 |
64 | Hypergammaglobulinemia (HP:0010702) | 2.53483055 |
65 | Inflammation of the large intestine (HP:0002037) | 2.52946561 |
66 | Combined immunodeficiency (HP:0005387) | 2.48445071 |
67 | Abnormality of the pleura (HP:0002103) | 2.41943563 |
68 | Increased cerebral lipofuscin (HP:0011813) | 2.34731733 |
69 | B lymphocytopenia (HP:0010976) | 2.33180332 |
70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31597146 |
71 | Petechiae (HP:0000967) | 2.31161191 |
72 | Gastrointestinal inflammation (HP:0004386) | 2.30618321 |
73 | Stomach cancer (HP:0012126) | 2.28015985 |
74 | Anorexia (HP:0002039) | 2.26102941 |
75 | Prostate neoplasm (HP:0100787) | 2.25821559 |
76 | IgM deficiency (HP:0002850) | 2.25181656 |
77 | Acute hepatic failure (HP:0006554) | 2.25171111 |
78 | Hypoproteinemia (HP:0003075) | 2.18028668 |
79 | Lymphopenia (HP:0001888) | 2.15414375 |
80 | Alveolar cell carcinoma (HP:0006519) | 2.14081466 |
81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11428334 |
82 | Polyneuropathy (HP:0001271) | 2.08090896 |
83 | Glomerulopathy (HP:0100820) | 2.08061175 |
84 | Colitis (HP:0002583) | 2.05912442 |
85 | Episodic fever (HP:0001954) | 2.05537977 |
86 | Vertigo (HP:0002321) | 2.05039821 |
87 | Skin rash (HP:0000988) | 2.01395269 |
88 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.01189462 |
89 | Cellulitis (HP:0100658) | 2.00124398 |
90 | Joint swelling (HP:0001386) | 1.98533627 |
91 | Peritonitis (HP:0002586) | 1.93759144 |
92 | Systemic lupus erythematosus (HP:0002725) | 1.92335037 |
93 | Keratitis (HP:0000491) | 1.91200814 |
94 | Amyloidosis (HP:0011034) | 1.90788279 |
95 | Osteomyelitis (HP:0002754) | 1.87452174 |
96 | Purpura (HP:0000979) | 1.85486331 |
97 | Papilloma (HP:0012740) | 1.84173705 |
98 | Verrucae (HP:0200043) | 1.84173705 |
99 | Aplastic anemia (HP:0001915) | 1.83961818 |
100 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.83628014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 4.80231646 |
2 | RIPK4 | 3.48608655 |
3 | MAP4K1 | 3.40044213 |
4 | FES | 3.13453903 |
5 | TAOK3 | 3.01452547 |
6 | BLK | 2.71877678 |
7 | IKBKE | 2.42909322 |
8 | CSK | 2.38750946 |
9 | TYK2 | 2.28321876 |
10 | MAP3K14 | 2.27828886 |
11 | JAK3 | 2.20449846 |
12 | KIT | 2.19054656 |
13 | SYK | 2.17302298 |
14 | BTK | 2.14350587 |
15 | GRK6 | 2.13010372 |
16 | ITK | 2.10976826 |
17 | BMPR2 | 2.09499992 |
18 | IRAK4 | 2.07123130 |
19 | ZAP70 | 2.06315565 |
20 | TEC | 1.99890798 |
21 | TBK1 | 1.94158518 |
22 | IKBKB | 1.89658706 |
23 | HCK | 1.69001389 |
24 | LYN | 1.63115135 |
25 | CSF1R | 1.60969187 |
26 | GRK7 | 1.59160953 |
27 | TNK2 | 1.58219975 |
28 | KDR | 1.57447171 |
29 | JAK1 | 1.54957384 |
30 | LCK | 1.54727864 |
31 | TESK2 | 1.51075176 |
32 | PIK3CG | 1.47757851 |
33 | MAP2K3 | 1.43121384 |
34 | FRK | 1.38864237 |
35 | MAP3K13 | 1.16466986 |
36 | JAK2 | 1.13906145 |
37 | MATK | 1.13245377 |
38 | CAMKK2 | 1.12894668 |
39 | TGFBR2 | 1.09297270 |
40 | MARK3 | 1.05549458 |
41 | ADRBK2 | 1.03346331 |
42 | TLK1 | 0.96276627 |
43 | IRAK1 | 0.91970512 |
44 | PRKCQ | 0.91527695 |
45 | FGR | 0.88599655 |
46 | MAP3K3 | 0.88565561 |
47 | MAP3K11 | 0.85460699 |
48 | PIM1 | 0.84019517 |
49 | INSRR | 0.81170831 |
50 | STK10 | 0.80264912 |
51 | SIK3 | 0.75416286 |
52 | PRPF4B | 0.73975703 |
53 | ERN1 | 0.72582359 |
54 | TRPM7 | 0.71119506 |
55 | CHUK | 0.68122429 |
56 | MAPK7 | 0.65781911 |
57 | PDK1 | 0.65372850 |
58 | FYN | 0.58200398 |
59 | SIK2 | 0.56091496 |
60 | PTK2B | 0.54160014 |
61 | HIPK2 | 0.51825774 |
62 | CAMKK1 | 0.51607132 |
63 | EPHB1 | 0.51564829 |
64 | IGF1R | 0.50638460 |
65 | MAP2K6 | 0.49707199 |
66 | MAP3K1 | 0.49249140 |
67 | FGFR3 | 0.48008979 |
68 | ABL1 | 0.46536318 |
69 | MAP2K2 | 0.46418043 |
70 | CDK4 | 0.44391510 |
71 | MAPK12 | 0.44293657 |
72 | MST4 | 0.42994631 |
73 | ACVR1B | 0.41730882 |
74 | RPS6KA6 | 0.40568065 |
75 | IRAK2 | 0.40515107 |
76 | MAPKAPK2 | 0.39218177 |
77 | ADRBK1 | 0.38447320 |
78 | MAP3K6 | 0.38405926 |
79 | MAPK11 | 0.36256379 |
80 | MAP3K5 | 0.35708527 |
81 | NLK | 0.35328672 |
82 | RPS6KL1 | 0.35322562 |
83 | RPS6KC1 | 0.35322562 |
84 | EGFR | 0.34701299 |
85 | NUAK1 | 0.32638463 |
86 | LRRK2 | 0.30291503 |
87 | MOS | 0.29987620 |
88 | DAPK2 | 0.29365732 |
89 | GRK5 | 0.29032283 |
90 | WNK1 | 0.28802618 |
91 | PDPK1 | 0.27783471 |
92 | PRKCD | 0.27302052 |
93 | CDK6 | 0.26792041 |
94 | TAOK2 | 0.26604082 |
95 | CDK19 | 0.25461133 |
96 | ZAK | 0.24634724 |
97 | MAPK3 | 0.24339501 |
98 | MAP3K12 | 0.23177382 |
99 | NEK6 | 0.21707774 |
100 | MAPKAPK3 | 0.21495511 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.59575767 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.58697445 |
3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.35832355 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.34980562 |
5 | Asthma_Homo sapiens_hsa05310 | 2.98360198 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81388329 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.77552716 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.72735707 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.67548325 |
10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.64407731 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.56443292 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.25660054 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.20886874 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20613425 |
15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.12701398 |
16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05284377 |
17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00458714 |
18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.95142857 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86845982 |
20 | Measles_Homo sapiens_hsa05162 | 1.83113746 |
21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83074400 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82631207 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80867972 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.79889183 |
25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70085984 |
26 | Malaria_Homo sapiens_hsa05144 | 1.66989992 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45032873 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.43991647 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.43303024 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41378922 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31452096 |
32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31286498 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30831733 |
34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29078854 |
35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26829626 |
36 | Pertussis_Homo sapiens_hsa05133 | 1.22054379 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15027006 |
38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12032681 |
39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03734477 |
40 | Platelet activation_Homo sapiens_hsa04611 | 1.02023722 |
41 | Phagosome_Homo sapiens_hsa04145 | 0.97037643 |
42 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96972787 |
43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95846448 |
44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92532774 |
45 | Shigellosis_Homo sapiens_hsa05131 | 0.87644814 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 0.86651550 |
47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83011853 |
48 | Lysosome_Homo sapiens_hsa04142 | 0.76292226 |
49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75665327 |
50 | Hepatitis B_Homo sapiens_hsa05161 | 0.74419588 |
51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72877439 |
52 | Apoptosis_Homo sapiens_hsa04210 | 0.72691424 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 0.64908488 |
54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64869775 |
55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64428774 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62921934 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60019248 |
58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58595387 |
59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57119203 |
60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45928128 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45530522 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45206038 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39969709 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39259446 |
65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37651536 |
66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37629183 |
67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37356599 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37302751 |
69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36781199 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36282931 |
71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35919345 |
72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34905122 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34001169 |
74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33106131 |
75 | Endocytosis_Homo sapiens_hsa04144 | 0.33080300 |
76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30737841 |
77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30573016 |
78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28404999 |
79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27019420 |
80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26547775 |
81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23922902 |
82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23253329 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22391788 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21122101 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20955395 |
86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20482974 |
87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18620985 |
88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18286051 |
89 | Insulin resistance_Homo sapiens_hsa04931 | 0.18038871 |
90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17201421 |
91 | Amoebiasis_Homo sapiens_hsa05146 | 0.16282236 |
92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.16188722 |
93 | Phototransduction_Homo sapiens_hsa04744 | 0.16044105 |
94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15119131 |
95 | Morphine addiction_Homo sapiens_hsa05032 | 0.14736065 |
96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.14426327 |
97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13292976 |
98 | Renin secretion_Homo sapiens_hsa04924 | 0.12708699 |
99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.12675252 |
100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.12064472 |